Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
69470 | Journal of Molecular Catalysis B: Enzymatic | 2015 | 4 Pages |
•(R)-2-(anthracen-9-yl)-2-methoxyacetic acid was obtained using the reduction α-ketoester.•Enzymatic reduction was carried out using Saccharomyces cerevisiae and Aureobasidium pullulans.•Antimycotic agent Boni Protect containing live A. pullulans cells is the best catalyst.
Optically pure (R)-2-(anthracen-9-yl)-2-methoxyacetic acid ((R)-9-AMA) was obtained. The most important stage of the synthesis generating chirality and ensuring high enantioselectivity was the stage of desymmetrization of prochiral α-ketoester. Enzymatic biotransformation was used in the presence of Saccharomyces cerevisiae and Aureobasidium pullulans. Biotransformation using S. cerevisiae leads to 65–70% enantiomeric excess (R-isomer). The antimycotic agent Boni Protect containing live cells of A. pullulans allowed to obtain enantiomerically pure (R)-9-AMA.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide